The Promise and Perils of Biotech in Personalised Healthcare. Can New Regulatory Pathways Protect the Vulnerable?

Risk and Regulation Magazine 32 (Winter 2018):20-23 (2018)
  Copy   BIBTEX

Abstract

The paper discusses some of the implications of regulatory innovation in the area of advanced biological therapies and personalised medicine. Benefits, risks and trade-offs are highlighted.

Categories

Keywords

Reprint years

Links

PhilArchive

External links

  • This entry has no external links. Add one.
Setup an account with your affiliations in order to access resources via your University's proxy server

Through your library

My notes

Similar books and articles

Personalised Medicine: A Critique on the Future of Health Care. [REVIEW]Jacqueline Savard - 2013 - Journal of Bioethical Inquiry 10 (2):197-203.
Evidence for personalised medicine: mechanisms, correlation, and new kinds of black box.Mary Jean Walker, Justin Bourke & Katrina Hutchison - 2019 - Theoretical Medicine and Bioethics 40 (2):103-121.
The Ethics of Expectations: Biobanks and the Promise of Personalised Medicine.Alan Petersen - 2009 - Monash Bioethics Review 28 (1):22-33.
Medical Profiling and Online Medicine: The Ethics of ‘Personalised Healthcare’ in a Consumer Age.[author unknown] - 2012 - Jahrbuch für Wissenschaft Und Ethik 16 (1):441-446.
Jochen Vollmann, Verena Sandow, Sabastian Wäscher, and Jan Schildmann : The ethics of personalised medicine: critical perspectives: Ashgate Publishing Limited, 2015, 285 pp, ISBN: 978-1-4724-4796-8.Silviya Aleksandrova-Yankulovska - 2017 - Theoretical Medicine and Bioethics 38 (1):89-94.
Individualised and personalised QALYs in exceptional treatment decisions.Warwick Heale - 2016 - Journal of Medical Ethics 42 (10):665-671.
Why we wrote … Medical profiling and online medicine: the ethics of 'personalised healthcare' in a consumer age.Hugh Whittall - 2011 - Clinical Ethics 6 (2):97-100.
Direct-to-Consumer Genetic Testing: How the Promise of a Personalised Approach is Being Squandered.H. Belt - unknown
More personal, better and cheaper? A critical analysis of “personalised medicine”.Jochen Vollmann - 2013 - Ethik in der Medizin 25 (3):233-241.
Protecting and respecting the vulnerable: existing regulations or further protections?Stephanie R. Solomon - 2013 - Theoretical Medicine and Bioethics 34 (1):17-28.
Defining ‘medical necessity’ in an age of personalised medicine: A view from Canada.Timothy Caulfield & Amy Zarzeczny - 2014 - Bioessays 36 (9):813-817.
The Ontology of Personhood: Distinguishing Sober from Enthusiastic Personalised Medicine.Therese Feiler - 2019 - Studies in Christian Ethics 32 (2):254-270.
European Association of Centres of Medical Ethics (EACME) Annual Conference: „Personalised medicine“: medicine for the person? Ethical challenges for medical research and practice.Tobias Fischer - 2014 - Ethik in der Medizin 26 (4):349-352.
Does anyone know the road from a randomized trial to personalized medicine? A review of ‘Treating Individuals. From Randomized Trials to Personalised Medicine’Peter M. Rothwell.Eyal Shahar - 2008 - Journal of Evaluation in Clinical Practice 14 (5):726-731.
The ethics of personal genetic profiling.Christopher Hood - 2010 - Genomics, Society and Policy 6 (1):1-5.

Analytics

Added to PP
2019-04-01

Downloads
159 (#115,388)

6 months
46 (#84,461)

Historical graph of downloads
How can I increase my downloads?

Author's Profile

Giovanni De Grandis
Norwegian University of Science and Technology

Citations of this work

No citations found.

Add more citations

References found in this work

No references found.

Add more references